India Generics Makers Fear Added Legal Exposure From U.S. FDA Move
This article was originally published in PharmAsia News
Executive Summary
India drug makers face the possibility of an onslaught of U.S.-based lawsuits if the U.S. FDA allows generics makers to update safety warnings on labels.